CT
Healthcare & Life Sciences
Cyteir Therapeutics
United Statescyteir.com
Cyteir Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
4
Investors
About Cyteir Therapeutics
Cyteir Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Cyteir Therapeutics is a clinical-stage oncology company developing CYT-0851, an oral drug candidate targeting monocarboxylate transporters, currently in Phase 1/2 trials for advanced ovarian cancer in combination with chemotherapy agents.
Explore Cyteir Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.